Thursday, July 15, 2010

$2.6B for Covidien to acquire ev3

In early June, Covidien reached an agreement to acquire Midwest-based endovascular company ev3, Inc.

ev3 manufactures angioplasty balloons, stents, and other supplies used to treat vascular diseases.

The acquisition of ev3 will allow Covidien to become a larger player in the medical equipment field, and will significantly expand its presence in the vascular device market.

Click here to read more in the ev3 company announcement.

No comments: